Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Merck
Covington
McKinsey
Teva
Citi
UBS
Mallinckrodt
AstraZeneca
Julphar

Generated: December 11, 2017

DrugPatentWatch Database Preview

AZACTAM Drug Profile

« Back to Dashboard

When do Azactam patents expire, and what generic alternatives are available?

Azactam is a drug marketed by Bristol Myers Squibb and is included in two NDAs.

The generic ingredient in AZACTAM is aztreonam. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aztreonam profile page.
Drug patent expirations by year for AZACTAM

Pharmacology for AZACTAM

Ingredient-typeMonobactams
Drug ClassMonobactam Antibacterial

Medical Subject Heading (MeSH) Categories for AZACTAM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Bristol Myers SquibbAZACTAMaztreonamINJECTABLE;INJECTION050580-002Dec 31, 1986APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbAZACTAM IN PLASTIC CONTAINERaztreonamINJECTABLE;INJECTION050632-003May 24, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbAZACTAMaztreonamINJECTABLE;INJECTION050580-003Dec 31, 1986APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbAZACTAMaztreonamINJECTABLE;INJECTION050580-001Dec 31, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbAZACTAM IN PLASTIC CONTAINERaztreonamINJECTABLE;INJECTION050632-001May 24, 1989RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbAZACTAM IN PLASTIC CONTAINERaztreonamINJECTABLE;INJECTION050632-002May 24, 1989RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Chinese Patent Office
Merck
Boehringer Ingelheim
Chubb
AstraZeneca
Harvard Business School
UBS
Queensland Health
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot